NanoCellect develops and delivers microfluidic-based solutions.
Its portfolio includes instruments and consumables for cell analysis and sorting. NanoCellect's technology was acquired by Nova Biomedical.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Its instruments and consumables enable biomedical scientists to analyze and sort cells for drug discovery, single-cell omics, cloning, antibody discovery, and basic research.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.Snapshot: September 12, 2026
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 12, 2026, September 14, 2026, September 16, 2026, September 18, 2026, September 19, 2026, September 29, 2026 and October 8, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.